Scientific work

Doç. Dr. Barış Demirkol

74 publications. The source of the information is stated next to each publication.

Back to profile

  1. Factors Associated With Diagnostic Accuracy of Robotic Bronchoscopy With 12-Month Follow-up

    The Annals of Thoracic Surgery, 2023

    DOI 10.1016/j.athoracsur.2021.12.041 PMID 35051388 35 citations (Europe PMC) Source: ORCID

  2. PROTECTIVE EFFICACY OF PIRFENIDONE IN RATS WITH PULMONARY FIBROSIS INDUCED BY BLEOMYCIN

    Sarcoidosis Vasculitis and Diffuse Lung Diseases, 2023

    DOI 10.36141/svdld.v40i3.13847 PMID 37712376 6 citations (Europe PMC) Open-access full textSource: ORCID

  3. The role of endobronchial ultrasonography elastography in the diagnosis of hilar and mediastinal lymph nodes

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2023

    DOI 10.55730/1300-0144.5634 PMID 37476908 4 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. The clinical, functional, and radiological effect of long-term used immunosuppressive therapy for post-COVID-19 interstitial lung disease.

    Sarcoidosis vasculitis and diffuse lung diseases, 2023

    DOI 10.36141/svdld.v40i4.15055 PMID 38126500 3 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. Serum Specific Antibodies Do Not Seem to Have an Additional Role in the Diagnosis of Hypersensitivity Pneumonitis

    La Medicina del Lavoro, 2023

    DOI 10.23749/mdl.v114i5.14478 PMID 37878260 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  6. The role of immunosuppressive therapy in post-COVID-19 interstitial lung disease

    European Respiratory Journal, 2023

    DOI 10.1183/13993003.congress-2023.pa4591 2 citations (OpenAlex) Source: OpenAlex

  7. Clinical Reflection of Pre- and Post-COVID-19 Symptoms in COVID-19 Patients

    Hamidiye Medical Journal, 2022

    DOI 10.4274/hamidiyemedj.galenos.2022.18480 Open-access full textSource: ORCID

  8. Modified successful desensitization protocol of infliximab in a patient with sarcoidosis unable to tolerate corticosteroids and refractory to alternative therapeutics

    Tuberk Toraks, 2022

    DOI 10.5578/tt.20229612 PMID 36537098 Open-access full textSource: ORCID

  9. Frequency of alpha-1 antitrypsin deficiency and unexpected results in COPD patients in Turkey; rare variants are common

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022

    DOI 10.55730/1300-0144.5486 PMID 36422500 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Restrictive Lung Diseases in Pregnancy

    Springer eBooks, 2022

    DOI 10.1007/978-3-031-05303-0_66 1 citation (OpenAlex) Source: OpenAlex

  11. Evaluation of repolarization dispersion in patients with idiopathic pulmonary fibrosis

    Medicine Science | International Medical Journal, 2022

    DOI 10.5455/medscience.2021.11.381 Open-access full textSource: OpenAlex

  12. PD-L1 expression correlation with metabolic parameters of 18F FDG PET/CT in nonsmall cell lung cancer>

    European Respiratory Journal, 2021

    DOI 10.1183/13993003.congress-2021.pa1870 Source: ORCID

  13. Assessment of epicardial adipose tissue thickness and total calcium score in sarcoidosis patients

    Archives of the Turkish Society of Cardiology, 2021

    DOI 10.5543/tkda.2020.74670 PMID 33390580 1 citation (Europe PMC) Source: ORCID

  14. Feasibility and safety of a novel electrosurgery device as part of multi-modal bronchoscopic therapy for malignant central airway lesions

    Journal of Thoracic Disease, 2021

    DOI 10.21037/jtd-20-3001 PMID 34164205 1 citation (Europe PMC) Open-access full textSource: ORCID

  15. TRANSBRONCHIAL CRYOBIOPSY FOR DIAGNOSING PARENCHYMAL LUNG DISEASES: REAL-LIFE EXPERIENCE FROM A TERTIARY REFERRAL CENTER

    Sarcoidosis Vasculitis and Diffuse Lung Diseases, 2021

    DOI 10.36141/svdld.v38i1.11029 PMID 33867791 4 citations (Europe PMC) Open-access full textSource: ORCID

  16. MA02.06 Factors Affecting the Diagnostic Yield of Robot-Assisted Bronchoscopy for Pulmonary Lesions

    Journal of Thoracic Oncology, 2021

    DOI 10.1016/j.jtho.2021.01.210 Open-access full textSource: OpenAlex

  17. Real life results of coil treatment for bronchoscopic lung volume reduction in emphysema

    Tuberk Toraks, 2020

    DOI 10.5578/tt.69320 PMID 32718136 1 citation (Europe PMC) Open-access full textSource: ORCID

  18. A comparative study of the effectiveness of hospital-based versus home-based pulmonary rehabilitation in candidates for bronchoscopic lung volume reduction

    Heart & Lung: The Journal of Acute and Critical Care, 2020

    DOI 10.1016/j.hrtlng.2020.06.011 PMID 32709500 6 citations (Europe PMC) Source: ORCID

  19. The Impact Of Co-Existing Comorbid Diseases On Long-Term Mortality In Bronchoscopic Lung Volume Reduction

    Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina, 2020

    DOI 10.17392/1043-20 PMID 31535544 2 citations (Europe PMC) Open-access full textSource: ORCID

  20. COVID-19'da Tanı

    Türkiye Klinikleri COVID - 19, 2020

    Source: OpenAlex

  21. The relationship between serum levels of surfactant protein D in COPD exacerbation severity and mortality

    Turkish Journal of Medical Sciences, 2019

    DOI 10.3906/sag-1809-6 PMID 31083857 4 citations (Europe PMC) Open-access full textSource: ORCID

  22. General features of patients with Pulmonary Langerhans Cell Histiocytosis followed in our instution

    Tuberkuloz ve Toraks, 2018

    DOI 10.5578/tt.67334 PMID 30479227 1 citation (Europe PMC) Open-access full textSource: ORCID

  23. The relationhip between serum levels of Surfactant protein D in COPD exacerbation severity and mortality

    European Respiratory Journal, 2018

    DOI 10.1183/13993003.congress-2018.pa4070 Source: ORCID

  24. Comorbidities And Mortality Of Patients With Severe Emphysema Evaluated For Bronchoscopic Lung Volume Reduction

    American Journal of Respiratory and Critical Care Medicine, 2017

    Source: ORCID